SLC31A1 and breast cancer: SLC31A1 expression is increased in cervical cancer, endometrial cancer (EC) and breast cancer (BC), but decreased in clear cell renal cell carcinoma (ccRCC), hepatocellular carcinoma (HCC) and lung adenocarcinoma (LUAD).